“For years, creatine has been known primarily as a supplement for increasing strength and muscle mass. But new research is drawing attention to its potential effects on the brain. In several clinical studies involving women with major depressive disorder who also experienced anxiety symptoms, taking creatine daily alongside standard…”
Plain restatementMultiple clinical trials show that daily creatine, added to standard psychiatric treatment, rapidly reduces anxiety symptoms (over 50% in two weeks) in women with major depressive disorder.
The post links to a real 2012 randomized trial by Lyoo and colleagues in the American Journal of Psychiatry. That trial tested creatine added to the antidepressant escitalopram in 52 women with major depressive disorder, and it found faster and greater improvement in depression scores in the creatine group, with a difference from placebo emerging around week 2 and continuing through week 8. However, the trial measured depression, not anxiety, and its headline number was a roughly 52 percent remission rate at week 8, not a "more than 50 percent reduction in anxiety after two weeks." The post also cites "Dechent et al., Translational Psychiatry" as its source, but that reference does not match the linked paper and no such review could be located. Independent reviewers of the creatine mental health literature note that anxiety benefit has not been established in dedicated trials. So the science on creatine and depression augmentation in women is genuine, but the specific anxiety claim in this post is not supported by the cited study.
[drifted from the evidence:] For years, creatine has been known primarily as a supplement for increasing strength and muscle mass. But new research is drawing attention to its potential effects on the brain. In several clinical [drifted from the evidence:] studies involving women with major depressive disorder who also experienced anxiety symptoms, taking creatine daily [drifted from the evidence:] alongside standard treatment [drifted from the evidence:] led to improvements beginning as early as the first week. After just two weeks, anxiety symptoms [drifted from the evidence:] had decreased by more than 50% in [drifted from the evidence:] some participants... Reference: Dechent et al., Translational Psychiatry: Review of the evidence on creatine and mental health (link to psychiatryonline.org 10.1176/appi.ajp.2012.12010009).
[added by the neutral restatement:] Multiple clinical [added by the neutral restatement:] trials show that daily [added by the neutral restatement:] creatine, added to standard [added by the neutral restatement:] psychiatric treatment, [added by the neutral restatement:] rapidly reduces anxiety symptoms [added by the neutral restatement:] (over 50% in [added by the neutral restatement:] two weeks) in women with major depressive disorder.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- A real RCT (Lyoo 2012) exists showing creatine augmentation of an SSRI accelerated and enhanced improvement in women with major depressive disorder.
- Improvements did emerge relatively early in the trial (by week 2) and continued through week 8.
- Proposed mechanisms in the literature do include brain energy metabolism, mitochondrial function, and neurotransmitter modulation.
- Interest in creatine for psychiatric/brain applications has genuinely grown.
- **Depression relabeled as anxiety.** The linked Lyoo 2012 study measured depression (HAM-D, MADRS, CGI). The post repeatedly frames the outcome as "anxiety symptoms." This is a category swap, not a summary.
- **"More than 50% reduction in anxiety after two weeks."** No such anxiety result is reported in Lyoo 2012. The 50%-ish figures in the actual study relate to *depression remission at week 8* (52% vs 25.9%), not two-week anxiety reduction.
- **Timing exaggeration.** The claim says improvements began "as early as the first week." The published trial reports the separation from placebo starting at week 2.
- **"Several clinical studies."** The specific women-with-MDD finding rests largely on a single small RCT (n=52), plus a related imaging follow-up in the same cohort. Bipolar and CBT-augmentation trials exist but do not replicate the specific anxiety framing.
- **Citation mismatch / likely fabricated reference.** The post cites "Dechent et al., Translational Psychiatry: Review of the evidence on creatine and mental health," but the URL points to Lyoo et al. 2012 in the American Journal of Psychiatry. No Dechent review in Translational Psychiatry on this topic could be located.
- Whether the post's author intended to refer to a specific anxiety subscale within HAM-D (which contains anxiety/somatic items). Even if so, "anxiety symptoms decreased more than 50% in two weeks" is not a headline finding of the paper.
- Whether "Dechent et al." is a genuine but mis-cited paper or an invented reference.
The linked study (Lyoo et al. 2012) is a real, peer-reviewed RCT of 52 women with major depressive disorder taking escitalopram, randomized to add-on creatine (3 g/day for week 1, then 5 g/day) or placebo for 8 weeks. By week 8, mean HAM-D scores had decreased from 26.9 to 5.4 in the creatine group, versus 26.7 to 9.8 in the placebo group (p < 0.001) . By week 8, significantly more participants in the creatine group achieved remission compared to placebo (52.0% vs. 25.9%; p = 0.008). The trial reported improved response in the creatine group as early as week 2 according to the scores on HAMD, MADRS and CGI , not week 1. The primary outcomes were depression scales, not anxiety scales. Independent summaries of the creatine mental-health literature note that anxiety improvement has not been conclusively demonstrated in large, stand-alone trials. More targeted studies are needed to determine whether creatine directly reduces anxiety symptoms.
Complete reasoning
The reply receipt is formatted for pasting into the thread where the claim is circulating.
Compact share page: verify.trueseeker.com/s/e2eabb5355e2/FJ4jwnM1YlefLQxauLjLdxj
Ask this case
Answers come only from the case file above; nothing is added.
Does the study linked in the post actually show creatine reduces anxiety symptoms?
No. The linked study by Lyoo and colleagues measured depression using scales like HAM-D and MADRS, not anxiety. The post's anxiety claim is not supported by that paper.
Where does the '50% improvement in two weeks' figure come from?
The actual study reported that about 52% of participants in the creatine group achieved depression remission by week 8, not a 50% reduction in anxiety after two weeks. The post appears to have reassigned that number to a different outcome and a different timepoint.
Is there real evidence that creatine helps with depression?
Yes. The Lyoo 2012 trial found that women with major depressive disorder who added creatine to their antidepressant showed greater and faster improvement in depression scores compared to placebo, with a difference emerging by week 2.
Is the 'Dechent et al., Translational Psychiatry' reference a real paper?
The investigation could not locate any such paper. The URL in the post leads to the Lyoo 2012 study in the American Journal of Psychiatry, which is a different author, journal, and article type entirely.
Does the post's claim rest on several clinical studies, as stated?
The specific finding about women with major depressive disorder comes largely from a single small trial of 52 participants, plus a follow-on imaging study using the same group. The investigation did not find multiple independent trials supporting the specific anxiety framing in the post.